NeoTract® Inc. is a Californian based company who is dedicated to develop innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. NeoTract® Inc. initial focus is to improve the standard of care for patients with Benign Prostatic Hyperplasia (BPH), a broadly underserved market. NeoTract Inc. first product is UROLIFT® System, a minimally invasive device designed to treat urinary tract symptoms (LUTS) due to BPH.
PURE Urology - BPH TREATMENT ALTERNATIVES
Urolift® System
Urolift® System is a minimally invasive approach to treating BPH that lifts or holds the enlarged prostate tissue out of the way so it no longer blocks the urethra. There is no cutting, heating or removal of prostate tissue.
Urolift® System offers:
-
- Immediate, visible result
- Rapid symptom relief
- No tissue removal or ablation
- Minimal downtime
- Preservation of sexual function
- Durable outcomes
- Urolift® System treatment does not preclude future Urolift, TURP or laser procedures
How Urolift® System does work?
Urolift® System: Significant Improvement Without Significant Downsides
L.I.F.T. Randomized Study Results Compared to AUA Guidelines at 1 year
0% Ejaculatory or Erectile Dysfunction – No instances of de novo, sustained erectile or ejaculatory dysfunction observed (L.IF.T. IDE Study. Roehrborn. J Urology 2013; 2/AUA BPH Guidelines 2003, 2010; 3/Naspro, Eur Urol 2009; 4/Montorsi, J Urol 2008).
Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure.
Results Reproducible – Across PUL Studies
Patients experienced rapid symptomatic improvement, increased urinary flow rates, preserved sexual function and a significant improvement in Quality of Life.
Urolift® System: Strong Clinical Results
-
- Can J Urol, USA Randomized (n=206, 3 yr)
- EU J Urol, BPH6 Randomized (n=80, 1 yr)
- Blad Dys Rep, Meta-Analysis
- Urology Practice, USA Randomized (n=206, 2 yr)
- J Urology, USA Randomized (n=206, 1 yr)
- J Sex Med, USA Sexual Function Analysis (n=140, 1 yr)
- BJUI, USA Crossover Study (n=51, 1 yr)
- Can J Urol, USA Local Study (n=51, 1 mo)
- EU J Urol, EU Multi-National Study (n=102, 1 yr)
- Urology J., 2 Year Multi-Center Study (n=64, 2 yr)
- J. Sex Med, Sexual Function Analysis (n=64)
- BJUI, First-in-lan Experience (n=19, 1 yr)
- Pop Health, Health Economics of Urolift
- Can J Urol, Technique
- Prog Urologie, French experience
- Urol Neur Uro, Spanish experience
Please, have a look on the here attached studies.
To order:
| Product Reference | Product Name/Description | Quantity |
|---|---|---|
| UL400-4 | Urolift set (4 Urolift® System) | x 1 |
Download our full range catalogue (.PDF).
Question directly your PURE Medical Device representative
PURE Medical Device ordering procedures